positron-emission-tomography

Documents about positron-emission-tomography

• A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma#894378ClinicalTrials.gov
• Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer#896703ClinicalTrials.gov
• Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke#897274ClinicalTrials.gov
• Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer#907527ClinicalTrials.gov
• Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)#980684ClinicalTrials.gov
• Short Dynamic 68GA-PSMA PET Reconstruction to Differentiate Urinary Excretion From Extra-urinary Uptakes With LAFOV-PET#624834HAL (France)
• Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 3#881641ClinicalTrials.gov
• CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer#811190ClinicalTrials.gov
• Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PET#811222ClinicalTrials.gov
• Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III#825532ClinicalTrials.gov
• Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.#838766ClinicalTrials.gov
• The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer#840987ClinicalTrials.gov
• A Study of XTR004 Radiotracer in Healthy Volunteers#861318ClinicalTrials.gov
• RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck#883403ClinicalTrials.gov
• Study of Different Gating Techniques for PET Image of Lung and Liver Lesions#910016ClinicalTrials.gov
• A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)#881604ClinicalTrials.gov
• Comparison Of Internal Dosimetry Evaluation Of Fluorine-18 Fluorodeoxyglucose (18f-Fdg) For Positron Emission Tomography (Pet) Using Olinda/Exm And Geant4 Monte Carlo Simulation#190847USM Repository
• Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease#807718ClinicalTrials.gov
• Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation#837212ClinicalTrials.gov
• Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises#847087ClinicalTrials.gov
• Validation of PET-MRI for Cardiovascular Disease#863975ClinicalTrials.gov
• Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging#864971ClinicalTrials.gov
• Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer#867288ClinicalTrials.gov
• Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma#871675ClinicalTrials.gov
• Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging#873102ClinicalTrials.gov
• Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases#887353ClinicalTrials.gov
• Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging#900391ClinicalTrials.gov
• Carotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR#901373ClinicalTrials.gov
• Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence#843616ClinicalTrials.gov
• Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum#5363Europe PMC
• Reference tissue uptake of [18F]PSMA-1007 in positron emission tomography of recurrent prostate cancer#348965Springer Nature OA
• A New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study.#430874NCBI PubMed Central
• Joint Reconstruction of Activity and Attenuation in PET by Diffusion Posterior Sampling in Wavelet Coefficient Space#677010HAL (France)
• To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)#807414ClinicalTrials.gov
• The Effect of Acetylcholine on Memory and Attention#866525ClinicalTrials.gov
• PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105#866550ClinicalTrials.gov
• Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System#876471ClinicalTrials.gov
• A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739#903335ClinicalTrials.gov
• Etanercept in Rheumatoid Arthritis and Vascular Inflammation#904174ClinicalTrials.gov
• Positron Emission Tomography (PET) Imaging of Reactive Oxygen and Nitrogen Species: Human Observation of Retention and Safety of [18F]-Fluoroedaravone#908593ClinicalTrials.gov
• Nefazodone in the Treatment of Social Phobia#967817ClinicalTrials.gov
• Positron Emission Tomography (PET) in Evaluating Cerebral Glucose Metabolism and Functional Change for Patients With Spinal Cord Injury#1010580ClinicalTrials.gov
• Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy#969894ClinicalTrials.gov
• Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [(18)F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study.#785451NCBI PubMed Central
• A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants#811002ClinicalTrials.gov
• Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma#825555ClinicalTrials.gov
• PET Imaging of Endotoxin-induced iNOS Activation#838670ClinicalTrials.gov
• Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)#849078ClinicalTrials.gov
• Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome#855241ClinicalTrials.gov
• First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia#865145ClinicalTrials.gov